Mack, M., Ranganathan, L., Bleul, S., Scherer, F.P., Werner, T.V., Winter, C.A. und The DKTK EXLIQUID consortium, [Study G. (2022) The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients [cd]. Freiburg: Universität. doi:10.1515/labmed-2022-0071.
Chicago Manual of Style 17th edition (full note)Mack, Matthias, Lavanya Ranganathan, Sabine Bleul, Florian Paul Scherer, Tamara Vanessa Werner, Christof Alexander Winter, und [Study Group] The DKTK EXLIQUID consortium. The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients. Cd. Freiburg: Universität, [2022?], Freiburg: Universität, [2022?]. https://doi.org/10.1515/labmed-2022-0071.
American Psychological Association 7th editionMack, M., Ranganathan, L., Bleul, S., Scherer, F. P., Werner, T. V., Winter, C. A., & The DKTK EXLIQUID consortium, [Study G. (ca. 2022). The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients [Cd]. Universität. https://doi.org/10.1515/labmed-2022-0071
Modern Language Association 9th editionMack, M., L. Ranganathan, S. Bleul, F. P. Scherer, T. V. Werner, C. A. Winter, und [Study G. The DKTK EXLIQUID consortium. The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients. cd, Universität, 2022, https://doi.org/10.1515/labmed-2022-0071.
ISO-690 (author-date, Deutsch)MACK, Matthias, Lavanya RANGANATHAN, Sabine BLEUL, Florian Paul SCHERER, Tamara Vanessa WERNER, Christof Alexander WINTER und [Study Group] THE DKTK EXLIQUID CONSORTIUM, 2022. The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients. Freiburg: Universität